Improved methods for testing antiresorptive compounds in human osteoclast cultures

Journal of Bone and Mineral Metabolism

Volumn 27, Issue 1, 2009, Pages 105-109

  Rissanen, Jukka P ^a   Ylipahkala, Hannele ^b   Fagerlund, Katja M ^b   Long, Clive ^c   Väänänen, H Kalervo ^b   Halleen, Jussi M ^a  

^a Pharmatest Services Ltd   (Finland)

^b UNIVERSITY OF TURKU   (Finland)

^c MERCK RESEARCH LABORATORIES   (United States)

Author keywords

CTX; Osteoclast activity; Osteoclast number; Osteoporosis; TRACP 5b

Indexed keywords

ALENDRONIC ACID; COLONY STIMULATING FACTOR 1; OSTEOCLAST DIFFERENTIATION FACTOR;

ARTICLE; CELL ACTIVITY; CELL CULTURE; CELL DIFFERENTIATION; CONTROLLED STUDY; HUMAN; HUMAN CELL; OSTEOCLAST; OSTEOLYSIS; PRIORITY JOURNAL;

ACID PHOSPHATASE; ANIMALS; BONE DENSITY CONSERVATION AGENTS; BONE RESORPTION; CATTLE; CELLS, CULTURED; COLLAGEN TYPE I; HUMANS; ISOENZYMES; OSTEOCLASTS;

EID: 58149181444     PISSN: 09148779     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00774-008-0002-1     Document Type: Article

References (17)

1. L Pierelli G Scambia G d'Onofrio M Ciarli A Fattorossi G Bonanno G Menichella A Battaglia P Benedetti Panici M Tommasi S Mancuso G Leone 1997 Generation of multinuclear tartrate-resistant acid phosphatase positive osteoclasts in liquid culture of purified human peripheral blood CD34+ progenitors Br J Haematol 96 64 69
2. JM Quinn J Elliott MT Gillespie TJ Martin 1998 A combination of osteoclast differentiation factor and macrophage-colony stimulating factor is sufficient for both human and mouse osteoclast formation in vitro Endocrinology 139 4424 4427
3. G Mbalaviele N Jaiswal A Meng L Cheng C Van Den Bos M Thiede 1999 Human mesenchymal stem cells promote human osteoclast differentiation from CD34+ bone marrow hematopoietic progenitors Endocrinology 140 3736 3743
4. A Boyde NN Ali SJ Jones 1984 Resorption of dentine by isolated osteoclasts in vitro Br Dent J 156 216 220
5. TJ Chambers PA Revell K Fuller NA Athanasou 1984 Resorption of bone by isolated rabbit osteoclasts J Cell Sci 66 383 399
6. K Selander P Lehenkari HK Väänänen 1994 The effects of bisphosphonates on the resorption cycle of isolated osteoclasts Calcif Tissue Int 55 368 375
7. S Christgau C Rosenquist P Alexandersen NH Bjarnason P Ravn C Fledelius C Herling P Qvist C Christiansen 1998 Clinical evaluation of the Serum CrossLaps One Step ELISA, a new assay measuring the serum concentration of bone-derived degradation products of type I collagen C-telopeptides Clin Chem 44 2290 2300
8. YZ Bagger NT Foged L Andersen H Lou P Qvist 1999 CrossLaps for culture: an improved enzyme-linked immunosorbent assay (ELISA) for measuring bone resorption in vitro J Bone Miner Res 14 suppl 1 S370 abstract
9. JM Halleen SL Alatalo H Suominen S Cheng AJ Janckila HK Väänänen 2000 Tartrate-resistant acid phosphatase 5b: a novel serum marker of bone resorption J Bone Miner Res 15 1337 1345
10. JJ Stepan E Silinkova-Malkova T Havranek J Formankova M Zichova J Lachmanova M Strakova P Broulik V Pacovsky 1983 Relationship of plasma tartrate resistant acid phosphatase to the bone isoenzyme of serum alkaline phosphatase in hyperparathyroidism Clin Chim Acta 133 189 200
11. SL Alatalo JM Halleen TA Hentunen J Mönkkönen HK Väänänen 2000 Rapid screening method for osteoclast differentiation in vitro that measures tartrate-resistant acid phosphatase 5b activity secreted into the culture medium Clin Chem 46 1751 1754
12. P Chu TY Chao YF Lin AJ Janckila LT Yam 2003 Correlation between histomorphometric parameters of bone resorption and serum type 5b tartrate-resistant acid phosphatase in uremic patients on maintenance hemodialysis Am J Kidney Dis 41 1052 1059
13. SL Alatalo Z Penq AJ Janckila H Kaija P Vihko HK Väänänen JM Halleen 2003 A novel immunoassay for the determination of tartrate-resistant acid phosphatase 5b from rat serum J Bone Miner Res 18 134 139
14. SL Alatalo KK Ivaska SG Waguespack MJ Econs HK Väänänen JM Halleen 2004 Osteoclast-derived serum tartrate-resistant acid phosphatase 5b in Albers-Schonberg disease (type II autosomal dominant osteopetrosis) Clin Chem 50 883 890
15. MG Sörensen K Henriksen S Schaller DB Henriksen FC Nielsen MH Dziegiel MA Karsdal 2007 Characterization of osteoclasts derived from CD14+ monocytes isolated from peripheral blood J Bone Miner Metab 25 36 45
16. RA Hannon JA Clowes AC Eagleton AA Al Hadari R Eastell A Blumsohn 2004 Clinical performance of immunoreactive tartrate resistant acid phosphatase isoform 5b as a marker of bone resorption Bone (NY) 34 187 194
17. A Nenonen S Cheng KK Ivaska SL Alatalo T Lehtimäki H Schmidt-Gayk K Uusi-Rasi A Heinonen P Kannus H Sievänen I Vuori HK Väänänen JM Halleen 2005 Serum TRACP 5b is a useful marker for monitoring alendronate treatment: comparison with other markers of bone turnover J Bone Miner Res 20 1804 1812